Literature DB >> 10362359

Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.

K Perrem1, T M Bryan, A Englezou, T Hackl, E L Moy, R R Reddel.   

Abstract

Some immortalized cell lines maintain their telomeres in the absence of detectable telomerase activity by an alternative (ALT) mechanism. To study how telomere maintenance is controlled in ALT cells, we have fused an ALT cell line GM847 (SV40 immortalized human skin fibroblasts) with normal fibroblasts or with telomerase positive immortal human cell lines and have examined their proliferative potential and telomere dynamics. The telomeres in ALT cells are characteristically very heterogeneous in length, ranging from very short to very long. The ALT x normal hybrids underwent a rapid reduction in telomeric DNA and entered a senescence-like state. Immortal segregants rapidly reverted to the ALT telomere phenotype. Fusion of ALT cells to telomerase-positive immortal cells in the same immortalization complementation group resulted in hybrids that appeared immortal and also exhibited repression of the ALT telomere phenotype. In these hybrids, which were all telomerase-positive, we observed an initial rapid loss of most long telomeres, followed either by gradual loss of the remaining long telomeres at a rate similar to the rate of telomere shortening in normal telomerase-negative cells, or by maintenance of shortened telomeres. These data indicate the existence of a mechanism of rapid telomere deletion in human cells. They also demonstrate that normal cells and at least some telomerase-positive immortal cells contain repressors of the ALT telomere phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362359     DOI: 10.1038/sj.onc.1202752

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.

Authors:  J F Riou; L Guittat; P Mailliet; A Laoui; E Renou; O Petitgenet; F Mégnin-Chanet; C Hélène; J L Mergny
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

3.  Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.

Authors:  K Perrem; L M Colgin; A A Neumann; T R Yeager; R R Reddel
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 4.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

5.  Telomerase activity in pleural malignant mesotheliomas.

Authors:  Amy Y M Au; Torben Hackl; Thomas R Yeager; Scott B Cohen; Harvey I Pass; Curtis C Harris; Roger R Reddel
Journal:  Lung Cancer       Date:  2011-01-31       Impact factor: 5.705

6.  Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops.

Authors:  Anthony J Cesare; Jack D Griffith
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies.

Authors:  Nicole Spardy; Anette Duensing; Elizabeth E Hoskins; Susanne I Wells; Stefan Duensing
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

8.  Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions.

Authors:  Anthony J Cesare; Zeenia Kaul; Scott B Cohen; Christine E Napier; Hilda A Pickett; Axel A Neumann; Roger R Reddel
Journal:  Nat Struct Mol Biol       Date:  2009-11-22       Impact factor: 15.369

9.  In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.

Authors:  Almira Nasirden; Tsuyoshi Saito; Yuki Fukumura; Kieko Hara; Keisuke Akaike; Aiko Kurisaki-Arakawa; Miki Asahina; Atsushi Yamashita; Ran Tomomasa; Takuo Hayashi; Atsushi Arakawa; Takashi Yao
Journal:  Virchows Arch       Date:  2016-10-07       Impact factor: 4.064

10.  DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.

Authors:  Jeremy D Henson; Ying Cao; Lily I Huschtscha; Andy C Chang; Amy Y M Au; Hilda A Pickett; Roger R Reddel
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.